RecruitingNot Applicable

Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur

Italy600 participantsStarted 2024-05-30

Plain-language summary

The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA or HHA or MegaTHA or Mega. After pre-screening the databases of the respective sites, the investigators expect to find approximately a total of 600 patients. A review will be made from the medical records, radiological imaging, and histological data of partecipants.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female adult patients surgically treated between 01/01/2000 and 31/12/2023 in Rizzoli Orthopaedic Institute and in Massachusetts General Hospital. * Age ≥18 y (at the time of surgery) * Patients with impending or pathological fracture due to bone metastases of the proximal femur (head/neck, intertrochanteric, subtrochanteric area). * Patients who underwent either IMN or THA or HHA or Mega or MegaTHA. * Patients with available clinical and imaging data. Exclusion Criteria: * Patients with pathological or impending fracture of proximal femur due to primary bone tumor.

What they're measuring

Analysis of implant survival

Timeframe: through study completion, an average of 1 year

Analysis of complications

Timeframe: At baseline ( T0)

Analysis of functional score

Timeframe: 1 year

Trial details

NCT IDNCT06918860

SponsorCostantino Errani

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Costantino Errani, MD

0516366 costantino.errani@ior.it

View on ClinicalTrials.gov More Bone Metastases trials